Abstract
This report provides extensive competitive comparison and evaluation of major
and emerging companies in the orthobiologics market covering key sectors:
alllograft tissue, demineralised bone matrix, growth factors, synthetic bone
graft, stem cell therapy, joint fluid therapy and cartilage repair.
The emergence and establishment of orthobiologic products and solutions is
expanding treatment options in orthopaedics from traditional metal implants,
plates and screws to biologically-based products for hard and soft tissue
regeneration. This new generation of products is fast gaining acceptance and
offers the potential to improve patient quality of life and reduce health
costs.
An intensely competitive market
The orthobiologics market is intensely competitive and is the fastest growing
segment of the global orthopaedics market. There is a constant need for bone
graft material to provide support, fill voids and enhance biologic repair of
skeletal defects. Of the more than three million musculoskeletal procedures
performed annually in the US, about half involve bone grafting with either an
autograft or an allograft. Worldwide, autografts and allografts are used in
approximately 2.2 million orthopaedic procedures annually.
Autograft bone has historically been the standard of care. This procedure is
well established among surgeons, has extensive long-term data and has remained
relatively unchanged for many years. However, its use is limited by donor-site
morbidity and supply. Allografts are suitable replacements for autografts, but
also have their limitations.
Owing to the limitations and associated problems inherent with these grafts,
alternative bone substitute materials have been sought. So far, many of these
have employed a variety of materials, including natural and synthetic
polymers, ceramics, and composites, whereas others have incorporated factor-
and cell-based strategies that are used either alone or in combination with
other materials. However, despite the many advances in bone graft substitutes,
to date, no ideal bone substitute has been found and there remains a real need
for an alternative with optimal bone regeneration properties.
The race is on...
Who will lead the race for market dominance in the future? What are the
emerging technologies that need to be watched? Who' s working with whom in this
high growth sector? The answers to these and thousands of other questions can
be found in this new, comprehensive and up-to-date report on the global
orthobiologics market, the companies involved and their products.
Highly competitive
In the highly competitive orthobiologics sector there appears to be a growing
preference towards the use of synthetic materials rather than traditional
autografts and allografts. Growth factors, in particular, bone morphogenic
proteins (BMPs) are also becoming increasingly popular, although their higher
cost is an ongoing issue.
Providing…
- Extensive competitive comparison and evaluation of major and emerging
companies
- Orthobiologics market valuation and markets in context
- Appraisal of products, research and innovation
Covering key sectors
- Allograft Tissue
- Demineralised Bone Matrix
- Growth Factors
- Synthetic Bone Graft
- Stem Cell Therapy
- Joint Fluid Therapy
- Cartilage Repair
| 
View Cart
